Rare diseases
Investigational molecules
Locations
J.h. Oortweg 21, 2333 CH Leiden, The Netherlands
Pharvaris Netherlands B.V. focuses on preventive treatment strategies for hereditary angioedema, with research centred on reducing the frequency of swelling attacks in adults and adolescents living with C1 inhibitor deficiency.
Its clinical portfolio includes work in both HAE due to C1-inhibitor deficiency and broader hereditary angioedema populations.
Pharvaris Netherlands B.V. runs clinical trials in conditions such as Hereditary angioedema, Hereditary angioedema with C1 esterase inhibitor deficiency, Acquired C1 inhibitor deficiency, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustriaAustria
BulgariaAustriaAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
